Fava bean peptides isolated by artificial intelligence performed better than traditional milk protein to improve muscle conditioning, according to a study supported by Irish biotechnology company Nuritas.
With a couple of ingredients already on the market for muscle and cellular aging, Nuritas’ next wave of artificial intelligence driven ingredient discoveries will target some big consumer health needs, including glucose management and very specialized...
The news that Nuritas has raised €40m ($45m) in funding brings into focus industry’s drive to not only add greater benefits to already functional foods but also achieve this in an environmentally friendly manner.
Nuritas has raised €40m ($45m) in the Irish biotech firm’s latest round of funding intended to finance global expansion efforts and potential new additions to its portfolio of plant-based bioactive peptides.
Nuritas is to provide Sumitomo Chemical with its Artificial Intelligence (AI)-powered peptide discovery services in a multi-year partnership that addresses food growth to satisfy a growing global population.
Nuritas once again harnesses Artificial Intelligence (AI) technology in the fight against the coronavirus as its platform is put to work identifying therapeutic peptides that modify the inflammatory response.